NCT01577667

Brief Summary

Partial automation of mechanical ventilation in resuscitation has been available for several years. New modalities are being developed to completely automate ventilation and oxygenation parameters (IntelliVent®. This pilot study compares over a 48h period the safety and efficacy of IntelliVent®, versus a conventional ventilation modality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2011

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 16, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

December 6, 2012

Status Verified

December 1, 2012

Enrollment Period

1.2 years

First QC Date

April 11, 2012

Last Update Submit

December 5, 2012

Conditions

Keywords

automationclosed loopoxygenationventilation

Outcome Measures

Primary Outcomes (1)

  • Safety

    Safety is assessed by measuring the number of times it is necessary to manually intervene on the ventilator settings because for one the following parameters: A range SpO2, EtCO2, plateau pressure (Pplat), tidal volume (VT), respiratory rate (RR) values considered as non-optimal, as defined a priori and consensually by a panel of experts.

    48 Hours

Secondary Outcomes (2)

  • Efficacy

    48 Hours

  • Care workload

    48H

Study Arms (2)

Conventional ventilation

NO INTERVENTION

Usual ventilation is administered according to the protocols implemented in the unit

Intellivent

EXPERIMENTAL

Intellivent is a ventilatory mode included in ventilator S1, Hamilton Medical. Intervention: the patient is ventilated with the same ventilator than in the conventionnal group; but the "ASV-Intellivent" ventilation has to be activated via a dedicated key on the ventilator screen. IntelliVent® activation requires selecting the kind of patient: ARDS, COPD and whether hemodynamic instability exists. The initial settings are IntelliVent® by default settings (% MV: 110%, PEEP: 5 cm H2O, FiO2: 60% - 100% in case of ARDS). Therefore modification of these various parameters is automatic. FiO2 and PEP are modified according to SpO2; %MV according to EtCO2.

Device: Intellivent; automatic mode implemented on a S1 ventilator

Interventions

Intellivent allows an automatic adjustment of the following parameters: FiO2, PEEP and %VM according to adjusted parameters: Size, SpO2 and EtCO2

Also known as: Closed-loop ventilation
Intellivent

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old
  • Patient under invasive ventilation for more than 6 hours and for a planned duration of at least 48 hours
  • Body Mass Index (current weight (kg)/height (m)²) \< 40
  • Signature of an informed consent by the family

You may not qualify if:

  • Need for ventricular assistance with intra-aortic balloon counterpulsation.
  • Presence of a bronchopleural fistula
  • Pregnant women: A pregnancy blood test will be performed in women of reproductive age. The results will be communicated to the patient by a physician of her choice.
  • Adults under guardianship
  • People deprived of freedom

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Polyvalent Intensive Care, St Luc Clinics

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

Respiratory InsufficiencyRespiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Pierre-François Laterre, Pr

    Reanimation, Cliniques Universitaires Saint Luc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2012

First Posted

April 16, 2012

Study Start

February 1, 2011

Primary Completion

April 1, 2012

Study Completion

June 1, 2012

Last Updated

December 6, 2012

Record last verified: 2012-12

Locations